Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1.
Pan Y, Shu G, Fu L, Huang K, Zhou X, Gui C, Liu H, Jin X, Chen M, Li P, Cen J, Feng Z, Lu J, Chen Z, Li J, Xu Q, Wang Y, Liang H, Wang Z, Deng Q, Chen W, Luo J, Yang J, Zhang J, Wei J. Pan Y, et al. Among authors: liang h. Adv Sci (Weinh). 2023 Apr;10(11):e2206792. doi: 10.1002/advs.202206792. Epub 2023 Feb 12. Adv Sci (Weinh). 2023. PMID: 36775874 Free PMC article.
Identification of ZDHHC1 as a Pyroptosis Inducer and Potential Target in the Establishment of Pyroptosis-Related Signature in Localized Prostate Cancer.
Luo CG, Gui CP, Huang GW, Chen JL, Li JY, Li PJ, Xu QH, Wang YH, Zhu JQ, Liang H, Wang Z, Deng Q, Cao JZ, Luo JH, Lu J, Chen W. Luo CG, et al. Among authors: liang h. Oxid Med Cell Longev. 2022 Dec 22;2022:5925817. doi: 10.1155/2022/5925817. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36589680 Free PMC article.
Neoadjuvant and adjuvant chemotherapy share equivalent efficacy in improving overall survival and cancer-specific survival among muscle invasive bladder cancer patients who undergo radical cystectomy: a retrospective cohort study based on SEER database.
Tan Z, Chen Z, Yao G, Mumin MA, Wang Y, Zhu J, Xu Q, Chen W, Liang H, Wang Z, Deng Q, Luo J, Wei J, Cao J. Tan Z, et al. Among authors: liang h. Transl Androl Urol. 2023 Feb 28;12(2):330-346. doi: 10.21037/tau-23-79. Epub 2023 Feb 27. Transl Androl Urol. 2023. PMID: 36915890 Free PMC article.
LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway.
Lu J, Fu LM, Cao Y, Fang Y, Cao JZ, Pan YH, Cen JJ, Liang YP, Chen ZH, Wei JH, Huang Y, Mumin MA, Xu QH, Wang YH, Zhu JQ, Liang H, Wang Z, Deng Q, Chen W, Jin XH, Liu ZP, Luo JH. Lu J, et al. Among authors: liang yp, liang h. Oncogene. 2023 May;42(19):1543-1557. doi: 10.1038/s41388-023-02666-x. Epub 2023 Mar 25. Oncogene. 2023. PMID: 36966254 Free PMC article.
Development and validation of a novel defined mutation classifier based on Lasso logistic regression for predicting the overall survival of immune checkpoint inhibitor therapy in renal cell carcinoma.
Chen M, Li P, Yao H, Liu F, Fu L, Wang Y, Zhu J, Xu Q, Liang H, Zhou Y, Wang Z, Deng Q, Chen W, Cao J, Chen X, Luo J. Chen M, et al. Among authors: liang h. Transl Androl Urol. 2023 Mar 31;12(3):406-424. doi: 10.21037/tau-23-21. Transl Androl Urol. 2023. PMID: 37032757 Free PMC article.
LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer.
Lin H, Fu L, Zhou X, Yu A, Chen Y, Liao W, Shu G, Zhang L, Tan L, Liang H, Wang Z, Deng Q, Wang J, Jin M, Chen Z, Wei J, Cao J, Chen W, Li X, Li P, Lu J, Luo J. Lin H, et al. Among authors: liang h. Cancer Lett. 2024 Jul 1;593:216807. doi: 10.1016/j.canlet.2024.216807. Epub 2024 Mar 8. Cancer Lett. 2024. PMID: 38462037
13,124 results
You have reached the last available page of results. Please see the User Guide for more information.